Cannara Biotech Inc. (TSXV:LOVE)

Cannara Biotech Statistics

Total Valuation

Cannara Biotech has a market cap or net worth of CAD 175.56 million. The enterprise value is 202.78 million.

Market Cap	175.56M
Enterprise Value	202.78M

Important Dates

The last earnings date was Tuesday, October 28, 2025.

Earnings Date	Oct 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Cannara Biotech has 94.90 million shares outstanding. The number of shares has increased by 0.64% in one year.

Current Share Class	94.90M
Shares Outstanding	94.90M
Shares Change (YoY)	+0.64%
Shares Change (QoQ)	+0.38%
Owned by Insiders (%)	2.20%
Owned by Institutions (%)	0.23%
Float	44.76M

Valuation Ratios

The trailing PE ratio is 13.21 and the forward PE ratio is 11.56.

PE Ratio	13.21
Forward PE	11.56
PS Ratio	1.64
PB Ratio	1.72
P/TBV Ratio	1.72
P/FCF Ratio	12.86
P/OCF Ratio	8.77
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.13, with an EV/FCF ratio of 14.85.

EV / Earnings	15.51
EV / Sales	1.89
EV / EBITDA	7.13
EV / EBIT	9.31
EV / FCF	14.85

Financial Position

The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.41.

Current Ratio	2.40
Quick Ratio	0.83
Debt / Equity	0.41
Debt / EBITDA	1.46
Debt / FCF	3.05
Interest Coverage	5.31

Financial Efficiency

Return on equity (ROE) is 13.75% and return on invested capital (ROIC) is 9.72%.

Return on Equity (ROE)	13.75%
Return on Assets (ROA)	8.42%
Return on Invested Capital (ROIC)	9.72%
Return on Capital Employed (ROCE)	16.19%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.66
Inventory Turnover	1.42

Taxes

In the past 12 months, Cannara Biotech has paid 5.02 million in taxes.

Income Tax	5.02M
Effective Tax Rate	27.74%

Stock Price Statistics

The stock price has increased by +172.06% in the last 52 weeks. The beta is 0.34, so Cannara Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.34
52-Week Price Change	+172.06%
50-Day Moving Average	1.71
200-Day Moving Average	1.53
Relative Strength Index (RSI)	65.73
Average Volume (20 Days)	47,834

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cannara Biotech had revenue of CAD 107.32 million and earned 13.08 million in profits. Earnings per share was 0.14.

Revenue	107.32M
Gross Profit	47.22M
Operating Income	21.77M
Pretax Income	18.10M
Net Income	13.08M
EBITDA	28.18M
EBIT	21.77M
Earnings Per Share (EPS)	0.14

Balance Sheet

The company has 14.36 million in cash and 41.58 million in debt, giving a net cash position of -27.22 million or -0.29 per share.

Cash & Cash Equivalents	14.36M
Total Debt	41.58M
Net Cash	-27.22M
Net Cash Per Share	-0.29
Equity (Book Value)	102.22M
Book Value Per Share	1.12
Working Capital	47.96M

Cash Flow

In the last 12 months, operating cash flow was 20.01 million and capital expenditures -6.36 million, giving a free cash flow of 13.65 million.

Operating Cash Flow	20.01M
Capital Expenditures	-6.36M
Free Cash Flow	13.65M
FCF Per Share	0.14

Margins

Gross margin is 44.00%, with operating and profit margins of 20.29% and 12.18%.

Gross Margin	44.00%
Operating Margin	20.29%
Pretax Margin	16.86%
Profit Margin	12.18%
EBITDA Margin	26.26%
EBIT Margin	20.29%
FCF Margin	12.72%

Dividends & Yields

Cannara Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.64%
Shareholder Yield	-0.64%
Earnings Yield	7.45%
FCF Yield	7.78%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on February 13, 2023. It was a reverse split with a ratio of 0.1.

Last Split Date	Feb 13, 2023
Split Type	Reverse
Split Ratio	0.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	8